FDA Investigator Leslie A Paul

Leslie A Paul has conducted inspections on 46 sites in 1 countries as of 22 Jan 2003. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
46
Last Inspection Date:
22 Jan 2003
Investigator Role:
FDA Investigator
Redica ID:
100004303
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Leslie A Paul:
Alanna L Mussawwir Bias, Alexandra A Carrico, Amanda M Dunneback, Amina Bashir, Amy S Graf, Anthony R Petriella, Art O Czabaniuk, Azza Talaat, Barbara A Rusin, Bei Y He, Bing Lin, Bleta Vuniqi, Brandi N Mcgrady, Brent M Dehaan, Brentley S Collins, Brian J Mundo, Brian M Campbell, Brian P Putz, Brittany A Mckenzie, Carl A Huffman, III, Carmen M Faraianu, Caroline H Le, Catherine D Djordjevic, Catherine V Quinlan, Cathie S Marshall, Charles A Snipes, PhD, Charles I Ann, Charles L Zhou, Chase S Baldwin, Chelsea J Falkowski, Cheng H Yen, Cheryl A Fuhs, Cheryl M Monroe, Christi L Bellmore, Christian D Lynch (CDL), Constantin Y Philopoulos, Corrine M Carter, Courtney E Hillier, Danial S Hutchison, Daniel B Arrecis, Daniel J Brown, Danny Tuntevski, Darren S Morgan, David J Gasparovich, David M Amy, David Perkins, Dawn C Olenjack, Donald W Myrick, Eliezar Ramos, Elizabeth J Rigoni, Elizabeth M Kelley, Elizabeth P Mayer, Emilie E Kahn, Emily E Krumel, Emily J Orban, Erin M Miller, Evan M Kupper, Gene D Arcy, Geneve M Maxwell, Geneve M Parks, George G Calafactor, Hassan M Fakhreddine, Helen B Ricalde, Ita Yuen, PhD, Jacob G Lutz, Jacqueline Mdiaz Albertini, James E Szelc, James K Ireland, James P Stallings, Janet L Bowen, Jayne E Holcomb, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Downie, Jennifer A Kemp, Joseph R Strelnik, Julia A Avery, Kelley L Clark, Larry K Austin, Laureen F Kononen, Lauren E Burke, Linda S Jozefiak, Lindsey M Schwierjohann, Lindsey S Fleischman, Lisa P Oakes, Logan M Ebeling, Margaret N Persich, Martha Sullivan Myrick, Matt D Suedkamp, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Miah I Schneider, Michael Y Philopoulos, Michele L Forster, PhD, Michele Perry Williams, Mihaly S Ligmond, Misty D Harvey, Myra K Casey, Nancy A Bellamy, Parul M Patel, Patsy J Domingo, Paula A Trost, Philip A Klimkewicz, Prabhu P Raju, Rabin N Ghoshal, Ralph A Erickson, Raymond R Roy, PhD, Rebecca E Dombrowski, Regina T Brown, Renee L Rice, PhD, Robert C Coleman, Robert G Taylor, Robert M Barbosa, Robert R Barbosa, Rohn R Robertson, Ronald G Crawford, Said H Muse, Sandra A Boyd, Sandra A Hughes, Sanket N Patel, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Sarah Nwandiuko, Sarah Rhoades, Sargum C Sood, Scott A Golladay, Sherri J Jackson, Sneha S Patel, Susan M Jackson, Susan P Bruederle, Tamayo C Barnes, Theodore N Sietsema, Thomas A Peter, Thomas J Cosgrove, Tonnie L Carter, Tracey Asinjen Wiersma, Tracey L Siebesma, Twana R Chandler, William D Tingley

Leslie A Paul's Documents

Publish Date Document Type Title
April, 2002 EIR L. Perrigo Company - EIR, 2002-04-23
July, 2002 EIR L. Perrigo Company - EIR, 2002-07-17
September, 2000 FDA 483 Justus J Fiechtner, P C. dba Fiechtner Research - Form 483, 2000-09-29
December, 2000 FDA 483 W. R. Grace & Co.-Conn. - Form 483, 2000-12-15
September, 2001 FDA 483 L. Perrigo Company - Form 483, 2001-09-21
March, 2000 FDA 483 Pfizer, Inc. - Form 483, 2000-03-30
February, 2001 FDA 483 Response Michigan Instruments, Inc. - Form 483R, 2001-03-01
August, 2002 EIR Pharmacia & Upjohn Company LLC - EIR, 2002-08-01
July, 2002 FDA 483 L. Perrigo Company - Form 483, 2002-07-17
June, 2002 FDA 483 Response DSC Laboratories, LLC - Form 483R, 2002-06-21
July, 2001 FDA 483 Lakeshore Technologies, LLC - Form 483, 2001-07-03
March, 2001 EIR L. Perrigo Company - EIR, 2001-03-21
June, 2002 FDA 483 DSC Laboratories, LLC - Form 483, 2002-06-11
September, 2002 FDA 483 Access Business Group LLC - Form 483, 2002-09-20
June, 2002 EIR DSC Laboratories, LLC - EIR, 2002-06-11
March, 2001 FDA 483 L. Perrigo Company - Form 483, 2001-03-21
September, 2002 EIR Access Business Group LLC - EIR, 2002-09-20
November, 2002 FDA 483 Response L. Perrigo Company - Form 483R, 2002-11-26
January, 2001 EIR Young, James, MD - EIR, 2001-01-16
February, 2001 EIR Michigan Instruments, Inc. - EIR, 2001-02-15
June, 2001 EIR SPI Pharma, Inc - EIR, 2001-06-28
December, 2000 EIR W. R. Grace & Co.-Conn. - EIR, 2000-12-15
September, 2000 EIR Fiechtner, Justus J. ,MD, PC - EIR, 2000-09-29
March, 2000 EIR Pfizer, Inc. - EIR, 2000-03-30
July, 2001 FDA 483 WelchDry Inc - Form 483, 2001-07-27
November, 2002 FDA 483 L. Perrigo Company - Form 483, 2002-11-08
September, 2001 EIR L. Perrigo Company - EIR, 2001-09-21
May, 2001 EIR Robert J. Bielski, MD - EIR, 2001-05-14
November, 2002 EIR L. Perrigo Company - EIR, 2002-11-08
October, 2001 EIR Mead Johnson & Company, LLC - EIR, 2001-10-17
January, 2001 FDA 483 Young, James, MD - Form 483, 2001-01-16
February, 2001 FDA 483 Michigan Instruments, Inc. - Form 483, 2001-02-15
March, 2002 FDA 483 Flier's Quality Water Systems, Inc. - Form 483, 2002-03-15
September, 2002 FDA 483 Response Access Business Group LLC - Form 483R, 2002-11-06

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more